MMI: Immunoassay Method, Troponin Subunit

Product code MMI, “Immunoassay Method, Troponin Subunit” in FDA's classification database, is a Class II device type under 21 CFR 862.1215 (creatine phosphokinase/creatine kinase or isoenzymes test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 95 clearances under MMI, 23 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
MMI
Regulation
21 CFR 862.1215
Class
II
Panel
Clinical Chemistry
Clearances
95
Most recent
Jun 11, 2026
Median review, last 2 years
266 days
Third-party review
Not eligible
Implant
No

What it covers

A creatine phosphokinase/creatine kinase or isoenzymes test system is a device intended to measure the activity of the enzyme creatine phosphokinase or its isoenzymes (a group of enzymes with similar biological activity) in plasma and serum. Measurements of creatine phosphokinase and its isoenzymes are used in the diagnosis and treatment of myocardial infarction and muscle diseases such as progressive, Duchenne-type muscular dystrophy.

The identification in 21 CFR 862.1215, creatine phosphokinase/creatine kinase or isoenzymes test system. FDA gives MMI no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K253051i-STAT hs-TnI cartridge with the i-STAT Alinity SystemAbbott Point of Care, Inc.Jun 11, 2026Traditional
K252393VITROS Immunodiagnostic Products hs Troponin I Reagent PackOrtho-Clinical Diagnostics, Inc.Oct 29, 2025Traditional
K243483Access hsTnIBeckman Coulter, Inc.Aug 1, 2025Traditional
K242870Access hsTnIBeckman Coulter, Inc.Jun 16, 2025Traditional
K240984i-STAT hs-TnI cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.Jan 3, 2025Traditional
K241165Atellica® IM High-Sensitivity Troponin I (TnIH)Siemens Healthcare Diagnostics, Inc.Jul 25, 2024Traditional
K231974PATHFAST®hs-cTnI-IIPhc CorporationMar 20, 2024Traditional
K222881Access hsTnIBeckman Coulter, Inc.Dec 18, 2023Traditional
K230648Access hsTnIBeckman Coulter, Inc.Dec 4, 2023Traditional
K230994Alinity i STAT High Sensitivity Troponin-IAbbott Laboratories Diagnostics DivisionMay 4, 2023Special
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 95 with a free account)

Clearances by year

23 MMI 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)1262
20254266
20242176
20233270
20221625
20211477
2019388
20184344
2017193
20132441
20111482

Who submits

8 applicants cleared a MMI device since 2011. 96% of the clearances went to applicants in United States, then Japan (4%). By type: Traditional 96% and Special 4%.

ApplicantClearances since 2011
Beckman Coulter, Inc.8
Siemens Healthcare Diagnostics, Inc.5
Abbott Laboratories Diagnostics Division3
Abbott Point of Care, Inc.2
Roche Diagnostics2
Mitsubishi Chemical Medience CO1
Ortho-Clinical Diagnostics, Inc.1
Phc Corporation1

How FDA classifies it

Class II.

From 21 CFR 862.1215.

Standards

21 CFR 862.1215 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MMI clearances declared.

Ask about MMI

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about MMI

What is FDA product code MMI?

Product code MMI, “Immunoassay Method, Troponin Subunit” in FDA's classification database, is a Class II device type under 21 CFR 862.1215 (creatine phosphokinase/creatine kinase or isoenzymes test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 95 clearances under MMI, 23 of them since 2011.

How many 510(k) clearances are there under MMI?

FDA’s 510(k) database listed 95 clearances under MMI as of Oct 29, 2026, 23 of them decided since 2011; the most recent decision was Jun 11, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a MMI 510(k)?

For the 5 MMI clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 266 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most MMI clearances?

Since 2011: Beckman Coulter, Inc. (8), Siemens Healthcare Diagnostics, Inc. (5), Abbott Laboratories Diagnostics Division (3), Abbott Point of Care, Inc. (2) and Roche Diagnostics (2). 8 applicants have cleared a MMI device in that time.

Sources

  1. FDA product classification: MMI · Product Classification database
  2. 21 CFR 862.1215: Creatine phosphokinase/creatine kinase or isoenzymes test system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for MMI · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow MMIGet an email when FDA clears, recalls or publishes guidance for MMI devices.

Know what FDA already cleared.